Table 3.
Medication | Number of cases in total N = 205,999 |
Frequency in total | Number of cases in suspected CAD N = 121,051 |
Frequency of cases in suspected CAD |
---|---|---|---|---|
Nitrates | 49,471 | 24.0% | 44,791 | 37.0% |
Beta-blockers—oral | 25,297 | 12.3% | 23,087 | 19.1% |
Beta-blockers—intravenous | 24,469 | 11.9% | 21,979 | 18.2% |
Ivabradine | 1097 | 0.5% | 1066 | 0.9% |
Sedation | 556 | 0.3% | 479 | 0.4% |
Premedication for contrast allergy | 416 | 0.2% | 264 | 0.2% |
Sodium perchlorate | 62 | 0.03% | 24 | 0.02% |
Calcium channel blocker | 19 | 0.01% | 17 | 0.01% |
Adenosine for myocardial perfusion study | 15 | 0.01% | 9 | 0.01% |
CAD coronary artery disease. N number of patients in category
Medications are not mutually exclusive due to different indications